Hepatoprotective effects of misoprostol and silymarin on carbon tetrachloride‐induced hepatic damage in rats
- 18 March 2009
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 23 (2) , 179-188
Abstract
The aim of this study was to investigate the effect of misoprostol, silymarin or the co‐administration of misoprostol + silymarin on the carbon tetrachloride (CCl4)‐induced hepatic injury in rats. Misoprostol (10, 100, 1000 μg/kg), silymarin (25 mg/kg) or misoprostol (100 μg/kg) + silymarin (25 mg/kg) was given once daily orally simultaneously with CCl4and for 15 days thereafter. The results showed that misoprostol (10, 100 or 1000 μg/kg) conferred significant protection against the hepatotoxic actions of CCl4in rats, reducing serum alanine aminotransferase (ALT) levels by 24.7%, 42.6% and 49.4%, respectively compared with controls. Misoprostol, given at 100 or 1000 μg/kg, decreased aspartate aminotransferase (AST) by 28 and 43.6% and alkaline phosphatase (ALP) by 19.3% and 53.4% respectively. Meanwhile, silymarin reduced ALT, AST and ALP levels by 62.7%, 66.1% and 65.1% respectively. The co‐administration of misoprostol (100 μg/kg) and silymarin (25 mg/kg) resulted in 61.4%, 66.1% and 57.5% reduction in ALT, AST and ALP levels respectively. Histopathological alterations and depletion of hepatocyte glycogen and DNA content by CCl4were markedly reduced after treatment with misoprostol, silymarin or misoprostol + silymarin. Image analysis of liver specimens revealed a marked reduction in liver necrosis; area of damage: 32.4%, 24% and 10.2% after misoprostol (10, 100 or 1000 μg/kg), 7.2% after silymarin and 10.9% after treatment with misoprostol 100 μg/kg + silymarin, compared with CCl4control group (46.7%). These results indicate that treatment with misoprostol protects against hepatocellular necrosis induced by CCl4. This study suggests a potential therapeutic use for misoprostol in liver injury.Keywords
This publication has 47 references indexed in Scilit:
- Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organJournal of Clinical Investigation, 2007
- Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDYJournal of Clinical Biochemistry and Nutrition, 2007
- The safety of misoprostolInternational Journal of Gynecology & Obstetrics, 2006
- The differential effect of PGE1 on d-galactosamine-induced nitrosative stress and cell death in primary culture of human hepatocytesProstaglandins & Other Lipid Mediators, 2006
- Diagnosis and treatment of chronic hepatitis C infectionBMJ, 2006
- Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological ModelCritical Reviews in Toxicology, 2003
- Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosisInt. Journal of Clinical Pharmacology and Therapeutics, 2002
- A Protective Role for Cyclooxygenase-2 in Drug-Induced Liver Injury in MiceChemical Research in Toxicology, 2001
- Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen α1(I) and TIMP-1Journal of Hepatology, 2001
- Assessment of the Carbon Tetrachloride-lnduced Cirrhosis Model for Studies of Nitrogen Metabolism in Chronic Liver DiseaseAnnals of Nutrition and Metabolism, 1994